Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
P 2 (1)

Trial Status

Recruiting3

Clinical Trials (3)

Showing 3 of 3 trials
NCT07560540Not ApplicableRecruiting

Nutritional Intervention Implication in Enhanced Recovery After Surgery for Whipple Procedure

NCT06001658Phase 2RecruitingPrimary

Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers

NCT07176962Recruiting

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

Showing all 3 trials

Research Network

Activity Timeline